Trial Profile
An Exploratory Study to Evaluate a Mixed Protocol of Menopur (Highly Purified Human Menopausal Gonadotropin) and REKOVELLE (Follitropin Delta) for Controlled Ovarian Stimulation in IVF (in Vitro Fertilization)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Follitropin delta (Primary) ; Menotropin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms MARCS
- 30 Nov 2020 Primary endpoint (Evaluate the number of utilizable blastocysts on Day 5 or Day 6 of embryo culture) has been met as per Results published in the Fertility and Sterility.
- 30 Nov 2020 Results published in the Fertility and Sterility
- 27 Aug 2019 Status changed from recruiting to completed.